| 英文别名 |
Darifenacin hydrobromide;{1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidnyl}-2,2-iphenylacetamide hydrobromide;(3S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-a-a-diphenyl-3-pyrrolidineacetamide Hydrobromide;Emsele;Enablex;DARIFENACIN HBR;Darifenacin Hydrobromid;3S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-α-a-diphenyl-3-pyrrolidineacetamide Hydrobromide;Emselex;3-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-, hydrobromide (1:1), (3S)-;Darifenacin (hydrobromide);Darifenacin HCl;2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide,hydrobromide;(3S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-3-pyrrolidineacetamide hydrobromide;UK 88525-04;{1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidnyl}-2,2-diphenylacetamide hydrobromide;Darifenacin hydrobro;DARFENACIN HYDROBROMIDE;UK-88525 hydrobromide;Darilong;UK 88525-04 hydrobromide;Darifenacinhydrobromide;NCGC00263922-02;(S)-2-(1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide hydrobromide;Uk-88525-04 (hbr);CHEBI:31455;Darifenacin 7.5 mg;133099-07-7 (HBr);Darifenacin hydrobromide (JAN/USAN);CS-0380;DARIFENACIN HYDROBROMIDE [EMA EPAR];3-Pyrrolidineacetamide, 1-(2-(2,3-dihydro-5-benzofuranyl)ethyl)-alpha,alpha-diphenyl-, monohydrobromide, (S)-;CHEMBL1200935;(S)-2-{1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidnyl}-2,2-diphenylacetamide hydrobromide;Darifenacin 15 mg;SW219426-1;DARIFENACIN HYDROBROMIDE [MART.];AS-35087;UK-88525-04;(S)-2-(1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenyl acetamide monohydribrimide;3-PYRROLIDINEACETAMIDE, 1-(2-(2,3-DIHYDRO-5-BENZOFURANYL)ETHYL)-alpha,alpha-DIPHENYL-, MONOHBR, (3S)-;Diphenyl-acetamide hydrobromide;Enablex (TN);2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide;hydrobromide;133099-07-7;Darifenacin hydrobromide [USAN];DARIFENACIN HYDROBROMIDE [ORANGE BOOK];DARIFENACIN HYDROBROMIDE [USP-RS];Q27114313;BD164350;AC-1894;EN300-123031;UQAVIASOPREUIT-VQIWEWKSSA-N;MFCD08141803;Z1546616192;3-Pyrrolidineacetamide, 1-(2-(2,3-dihydro-5-benzofuranyl)ethyl)-alpha,alpha-diphenyl-, monohydrobromide, (3S)-;CAS-133099-07-7;Tox21_112636_1;DARIFENACIN HYDROBROMIDE [MI];Tox21_112636;CCG-220969;Darifenacin hydrobromide- Bio-X;3-PYRROLIDINEACETAMIDE, 1-(2-(2,3-DIHYDRO-5-BENZOFURANYL)ETHYL)-.ALPHA.,.ALPHA.-DIPHENYL-, MONOHYDROBROMIDE, (3S)-;DARIFENACIN HYDROBROMIDE (MART.);3-PYRROLIDINEACETAMIDE, 1-[2-(2,3-DIHYDRO-5-BENZOFURANYL)ETHYL]-ALPHA,ALPHA-DIPHENYL-, HYDROBROMIDE (1:1), (3S)-;2-((3S)-1-(2-(2,3-dihydro-1-benzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide hydrobromide;Darifenacin hydrobromide, United States Pharmacopeia (USP) Reference Standard;(S)-2-{1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)-3-pyrrolidnyl}-2,2-diphenylacetamide hydrobromide;2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethy... |
微信公众号
客服
